Gregory Scott Day MD MSc MSCI FAAN FANA
Neurodegenerative, Dementia & Geriatrics
Associate Professor of Neurology
Join to View Full Profile
4500 San Pablo Rd SJacksonville, FL 32224
Phone+1 904-953-2000
Fax+1 904-953-0757
Dr. Day is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Washington University in St. LouisMSCI, Clinical Investigation, 2018 - 2020
Washington University/B-JH/SLCH ConsortiumFellowship, Memory and Aging, 2014 - 2015- University of TorontoResidency, 2009 - 2014
Queen's University at KingstonClass of 2009, MD- Queen's UniversityMSc, Neuroscience / Physiology, 2003 - 2006
Certifications & Licensure
FL State Medical License 2019 - 2026
MO State Medical License 2015 - 2020
American Board of Psychiatry and Neurology Neurology
Clinical Trials
- The ExTINGUISH Trial of Inebilizumab in NMDAR Encephalitis Start of enrollment: 2022 Mar 30
- Longitudinal Early-onset Alzheimer's Disease Study Protocol Start of enrollment: 2018 Apr 30
- COVID-19 Registry to Assess Frequency, Risk Factors, Management, and Outcomes of Arterial and Venous Thromboembolic Complications Start of enrollment: 2020 Mar 24
- Join now to see all
Publications & Presentations
PubMed
- The Clinical Trial Landscape in Autoimmune Encephalitis: Challenges and Opportunities.Hesham Abboud, Stacey L Clardy, Divyanshu Dubey, Jonathan Wickel, Gregory Scott Day
Neurology. 2025-04-22 - Characterizing and validating 12-month reliable cognitive change in Early-Onset Alzheimer's Disease for use in clinical trials.Dustin B Hammers, Jane Musema, Ani Eloyan, Maryanne Thangarajah, Alexander Taurone
The Journal of Prevention of Alzheimer's Disease. 2025-04-01 - Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer's disease: an open-label extension of the phase 2/3 multicentre, randomised, ...Randall J Bateman, Yan Li, Eric M McDade, Jorge J Llibre-Guerra, David B Clifford
The Lancet. Neurology. 2025-04-01
Press Mentions
Researchers Find Other Diseases May Mimic Rare Brain Disorder Linked to DementiaOctober 31st, 2022- How I Coped with Losing My Father to a Rare Neurodegenerative DiseaseSeptember 13th, 2021
Have a Parent with Dementia? Your Symptoms May Show up 6 Years EarlierNovember 26th, 2019- Join now to see all
Grant Support
- Bio-RaPID: Biomarkers and Rates of Progression In Dementia.MAYO CLINIC JACKSONVILLE2024–2029
- Rapidly Progressive Dementia: Moving Beyond CJDNational Institutes of Health2019–2023
Professional Memberships
- Member
External Links
- Anti-NMDA Receptor Encephalitis Foundationhttp://antinmdafoundation.org
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
